Last reviewed · How we verify

NCT03782805

Effect of Vitamin D Supplementation on Inflammatory Markers

Completed NA Last updated 21 December 2018
What this trial tests

NA trial testing cholecalciferol (Euro-Pharm International, Canada) in Vitamin D Deficiency in 88 participants. Completed in 9 July 2018.

Timeline
9 May 2018
Primary endpoint
7 June 2018
9 July 2018

Quick facts

Lead sponsorUniversité d'Auvergne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment88
Start date9 May 2018
Primary completion7 June 2018
Estimated completion9 July 2018
Sites1 location across Lebanon

Drugs / interventions tested

Conditions studied

Sponsor

Université d'Auvergne

Who can join

Adults 60 to 72, any sex, with Vitamin D Deficiency or Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Previous studies have shown that improving vitamin D status among the elderly may lead to an improvement in some inflammatory markers, especially with patients with type 2 diabetes. The aim of our trial is study the effect of vitamin D supplementation on inflammatory markers in patients having type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    El Hajj C, Walrand S, Helou M, Yammine K. · · 2020 · cited 37× · PMID 32659891 · DOI 10.3390/nu12072033

Verify or expand the search:

Other trials of cholecalciferol (Euro-Pharm International, Canada)

Trials testing the same drug.

Other recruiting trials for Vitamin D Deficiency

Currently open trials in the same condition.

Other Université d'Auvergne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03782805.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing